Regorafenib dose modifications in patients with metastatic colorectal cancer in the phase III CORRECT study

被引：0
|
作者：
Falcone, A. [1 ]
Van Cutsem, E. [2 ]
Sobrero, A. [3 ]
Siena, S. [4 ]
Ychou, M. [5 ]
Lenz, H. J. [6 ]
Yoshino, T. [7 ]
Cihon, F.
Wagner, A. [8 ]
Grothey, A. [9 ]
机构：
[1] Azienda Osped Univ Pisana, UO Oncol Med, Pisa, Italy
[2] Katholieke Univ Leuven Hosp, Louvain, Belgium
[3] Osped San Martino Genova, Genoa, Italy
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] ICM Val dAurelle, Montpellier, France
[6] VSC Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA USA
[7] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
[8] Bayer Pharma AG, Global Clin Dev Oncol, Berlin, Germany
[9] Mayo Clin, Dept Oncol, Rochester, MN USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2360
引用
收藏
页码：S546 / S546
页数：1
相关论文
共 50 条
  • [1] Regorafenib dose modifications in patients with metastatic colorectal cancer in the phase III CORRECT study
    Karthaus, M.
    Falcone, A.
    van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Ychou, M.
    Lenz, H. J.
    Yoshino, T.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 39 - 39
  • [2] Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC)
    Van Cutsem, Eric
    Sobrero, Alberto F.
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz-Josef
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Wagner, Andrea
    Laurent, Dirk
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Analysis of plasma protein biomarkers from the CORRECT phase III study of regorafenib for metastatic colorectal cancer
    Karthaus, M.
    Lenz, H-J
    van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Falcone, A.
    Ychou, M.
    Humblet, Y.
    Bouche, O.
    Mineur, L.
    Barone, C.
    Adenis, A.
    Tabernero, J.
    Yoshino, T.
    Goldberg, R. M.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    ONKOLOGIE, 2013, 36 : 70 - 70
  • [4] SAFETY AND EFFICACY OF REGORAFENIB IN JAPANESE PATIENTS WITH METASTATIC COLORECTAL CANCER: A SUBGROUP ANALYSIS OF THE PHASE III CORRECT TRIAL
    Yamada, Y.
    Yoshino, T.
    Komatsu, Y.
    Yamazaki, K.
    Tsuji, A.
    Ura, T.
    Grothey, A.
    Van Cutsem, E.
    Wagner, A.
    Ohtsu, A.
    ANNALS OF ONCOLOGY, 2013, 24
  • [5] Safety and tolerability of regorafenib (REG) in Italian patients: Subgroup analysis of the phase III CORRECT study in metastatic colorectal cancer (mCRC)
    Sobrero, Alberto F.
    Falcone, Alfredo
    Barone, Carlo
    Zaniboni, Alberto
    Clardlello, Fortunato
    Luppi, Gabriela
    Carteni, Giacomo
    Carpani, Daniela
    Curzlo, Daniela
    Boni, Corrado
    Siena, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Effects of regorafenib therapy on health-related quality of life in patients with metastatic colorectal cancer in the phase III CORRECT study
    Siena, S.
    Grothey, A.
    Sobrero, A.
    Falcone, A.
    Ychou, M.
    Lenz, H. J.
    Yoshino, T.
    Cihon, F.
    Pawar, V.
    Van Cutsem, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S482 - S482
  • [7] Effects of regorafenib therapy on health-related quality of life in patients with metastatic colorectal cancer in the phase III CORRECT study
    Stein, A.
    Siena, S.
    Grothey, A.
    Sobrero, A.
    Falcone, A.
    Ychou, M.
    Lenz, H. J.
    Yoshino, T.
    Cihon, F.
    Pawar, V.
    van Cutsem, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 40 - 40
  • [8] Analysis of plasma protein biomarkers from the CORRECT phase III study of regorafenib for metastatic colorectal cancer.
    Lenz, Heinz-Josef
    Van Cutsem, Eric
    Sobrero, Alberto F.
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Wagner, Andrea
    Laurent, Dirk
    Jeffers, Michael
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] PHASE 3 CORRECT TRIAL OF REGORAFENIB IN METASTATIC COLORECTAL CANCER (MCRC)
    Sobrero, Alberto
    Grothey, Axel
    Van Cutsem, Eric
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz Joseph
    Goldberg, Richard
    Sargent, Daniel
    Cihon, Frank
    Jeffers, Michael
    Wagner, Andrea
    Laurent, Dirk
    ANNALS OF ONCOLOGY, 2012, 23 : 15 - 16
  • [10] Population Pharmacokinetics Analysis of Regorafenib and its active Metabolites from the Phase III CORRECT study of metastatic colorectal cancer
    Karthaus, M.
    Trnkova, Z. Jirakova
    Grothey, A.
    Sobrero, A.
    Siena, S.
    Falcone, A.
    Ychou, M.
    Humblet, Y.
    Bouche, O.
    Mineur, L.
    Barone, C.
    Adenis, A.
    Tabernero, J.
    Yoshino, T.
    Lenz, H. J.
    Cihon, F.
    Reif, S.
    Laurent, D.
    Diefenbach, K.
    van Cutsem, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 39 - 39
12345